Robert Chess
3 stock trades in the last 12 months, shares they bought or sold themselves (not grants or options).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Every trade Robert Chess reported
| Stock | Trade | Amount | Traded |
|---|---|---|---|
| Sell(10b5-1 plan) | $2M | Aug 7SEC filing | |
| Sell(10b5-1 plan) | $470K | Mar 17SEC filing | |
| Sell | $105K | Feb 13SEC filing |
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Robert Chess' companies
| Stock | Trades | Quality Score |
|---|---|---|
| 0 | ||
| 3 |
Alerts for Robert Chess
Use this page
How to cite
Breakaway, Robert Chess: Director at Nektar Therapeutics (NKTR), Sep 23, 2026, getbreakaway.com/insiders/robert-chess
Journalists: email support@getbreakaway.com for the data behind this page.